Tuberculosis Treatment Outcomes in Europe: Based on Treatment Completion, Not Cure.
1 Heart of England Foundation Trust Birmingham, United Kingdom.|4 University of Warwick Coventry, United Kingdom.
Martin J
MJ
Dedicoat
2 Research Center Borstel Borstel, Germany.|3 University of Namibia School of Medicine Windhoek, Namibia.
Gunar
G
Günther
5 Institute of Phthisiopneumology Chişinău, Republic of Moldova.|6 National TB Reference Laboratory Chisinau, Republic of Moldova.
Valeriu
V
Crudu
7 Porto University Porto, Portugal.
Raquel
R
Duarte
8 National Institute for Infectious Diseases "L, Spallanzani" Rome, Italy.
Gina
G
Gualano
9 Radboud University Medical Centre Nijmegen/Groesbeek, the Netherlands.
Cecile
C
Magis-Escurra
10 Otto Wagner Hospital Vienna, Austria.
Rudolf
R
Rumetshofer
11 Republican Research and Practical Centre for Pulmonology and Tuberculosis Minsk, Belarus.
Alena
A
Skrahina
12 Marius-Nasta-Institut Bucharest, Romania.
Victor
V
Spinu
13 AOVV E. Morelli Reference Hospital for MDR and HIV-TB Sondalo, Italy.|14 Barts Health NHS Trust London, United Kingdom.
Simon
S
Tiberi
15 National Institute for Health Development Tallinn, Estonia.
Piret
P
Viiklepp
16 University of Amsterdam Amsterdam, the Netherlands.|17 Amsterdam Institute for Global Health and Development Amsterdam, the Netherlands.
Frank
F
van Leth
2 Research Center Borstel Borstel, Germany.|18 University of Lübeck Lübeck, Germany.|19 Karolinska Institute Stockholm, Sweden and.|20 German Center for Infection Research (DZIF) Borstel, Germany.
Christoph
0000-0002-9691-4741
C
Lange
D000995:Antitubercular Agents / Q000627:therapeutic use*; D015331:Cohort Studies; D046508:Culture Techniques; D005060:Europe; D015658:HIV Infections / Q000453:epidemiology; D006801:Humans; D016017:Odds Ratio; D011446:Prospective Studies; D013183:Sputum / Q000382:microbiology; D016896:Treatment Outcome; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy* / Q000453:epidemiology; D014944:World Health Organization
D000995:Antitubercular Agents